Key considerations for commercialisation of your advanced therapy research

OxTalks is Changing

During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).

If you have any questions, please contact halo@digital.ox.ac.uk

Key considerations for commercialisation of your advanced therapy research

The virtual event comprises a series of talks, breakouts and panel discussion on the key considerations for commercialisation and translation of cell and gene therapy research, and how to prepare and ensure commercial success for your advanced therapy projects.

Sessions include: Overcoming barriers to scale-up manufacturing, Addressing current and future pre-clinical ATMP development and regulatory needs and Considering your intellectual property and commercial needs

Date: 21 October 2020, 13:00
Venue: After registration via EventBrite, you will receive an access link to the virutal event up to one week before the event sent to the email address provided during registration.
Speaker: Various Speakers
Organising department: Medical Sciences Division
Organisers: Cell and Gene Therapy Catapult, Translational Research Office (Medical Sciences Division, University of Oxford)
Organiser contact email address: translationalresearchoffice@medsci.ox.ac.uk
Booking required?: Required
Booking url: https://www.eventbrite.co.uk/e/cgt-catapult-advanced-therapies-seminar-with-the-university-of-oxford-registration-122404072877
Audience: Members of the University only
This talk features in the following public collections:
- Talks of Interest to Medical Sciences
- Innovation & Translation related talks
Editor: Janice Young